Autoimmune Treatment Market

According to a new market research report, ‘Global Autoimmune Treatment Market (2009–2014)’, published by MarketsandMarkets (www.marketsandmarkets.com), the global autoimmune treatment market is expected to be worth US$68.81 billion by 2014, with an estimated CAGR of 12.7% from 2009 to 2014. The North American market is expected to account for nearly 42% of the total revenues.

Browse 100+ market data tables and in-depth TOC on autoimmune treatment market. Early buyers will receive 10% customization of reports
https://www.marketsandmarkets.com/Market-Reports/autoimmune-treatment-market-research-27.html

Autoimmune disorders result from an overactive immune response of a body working against its own cells. The disease is broadly classified into two types: systemic autoimmune diseases, which affect several organs of the body; and localized autoimmune diseases, which affect only one organ. Around 80 autoimmune diseases are recognized under these two categories. The disease affected over 300 million people across the globe in 2009. No defined reasons have been discovered to date for the occurrence of the disorder. Women are more prone to autoimmune diseases, constituting 70%-75% of all autoimmune patients. 

The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009 and is growing at a CAGR of 12.7% from 2009 to 2014. The market is forecasted to be at $68.81 billion in 2014. The effects of the global meltdown are given careful consideration when forecasting the market. As autoimmune disorders still have no permanent cure, more and more pharmaceutical companies are making significant R&D investments into finding treatments for autoimmune diseases, are also focusing on finding the causes behind the disease, which again are unknown.

The overall market for the treatment of autoimmune disorders is analyzed into the submarkets for applications, products, services, and technologies. The application market is further classified into the treatment markets for systemic autoimmune diseases and localized autoimmune diseases. The applications market is dominated mostly by rheumatoid arthritis under the systemic disease segment, while multiple sclerosis is the major application market under the localized disease segment. These two disorders  account for 75% of the total applications market. The other major diseases analysed under the application market are psoriasis, lupus, type I diabetes, inflammatory bowel disease, and thyroid disorders, which together account for 15%-20% of the global applications market.

The product market is classified on the basis of the drugs, diagnostic equipments, therapeutic and monitoring equipment. Drugs form the largest segment of the products market, with major drugs such as NSAID, DMARD, biologic DMARD, Avonex, Rebif, Copaxone, Betaseron, and 5-ASA. The services market consists of consultation and diagnosis, therapy and monitoring, and drug development. The wide and increasing prevalence of autoimmune diseases is boosting the drugs market along with the therapy and monitoring market; along with the fact that almost all autoimmune diseases are chronic and have no permanent cure.

Scope of the Report

• The report provides market overviews, market forecasts, market drivers and restraints for the autoimmune treatment market. In addition, the report profiles the top forty market players and their respective autoimmune products. The report identifies and analyzes the market according to application markets for both systemic and localized autoimmune diseases, product markets, services market, and technologies market.

 Autoimmune Treatment – Applications

• Systemic autoimmune diseases – rheumatoid arthritis, psoriasis, lupus and other systemic autoimmune diseases.
• Localized autoimmune diseases – multiple sclerosis, inflammatory bowel disease, diabetes, thyroid and other localized autoimmune diseases.

Autoimmune Treatment – Products
Drugs, diagnostic equipments, therapeutic and monitoring equipments and other products.

Autoimmune Treatment – Services
Consultation & Diagnosis, Therapy & Monitoring, Drug Development and other services.

Autoimmune Treatment – Technologies
DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARD therapy, Bridge therapy, Topical therapy, Phototherapy, Helminthic therapy, Fecal bacteriotherapy, Haematopoietic stem-cell transplantation, Recombinant technology

Analyst Briefings on 15th Sep 2009.

The Pharmaceuticals practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Autoimmune Treatment Market to be held on 15th Sep 2009. The briefing on the Global Autoimmune Treatment Market (2009-2014) will benefit the drug manufacturers, therapeutic and diagnostic equipment manufacturers, researchers and consultation and therapy service providers.

To register your participation, please click here https://www.marketsandmarkets.com/AnalystBriefing/analyst-briefing-global-autoimmune-treatment-market.asp

Contact our representative to sponsor this report

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.

Contact:
Ms. Sunita
108, West 13th Street,
Wilmington, DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: [email protected]